As of December 31, 2013, California skilled nursing providers reduced the unnecessary use of off-label antipsychotics by more than 18 percent, exceeding the national goal of a 15 percent reduction.
Background: In May, 2012, the Centers for Medicare and Medicaid Services (CMS) announced a "Partnership to Improve Dementia Care in Nursing Homes,” a public–private partnership to ensure appropriate care and use of off-label antipsychotic medication for nursing home patients.
This initiative continues to be promoted in California by a coalition of interested stakeholders including CAHF, California Department of Public Health Licensing and Certification, CMS Region IX, California Association of Long-Term Care Medicine, Health Services Advisory Group and others that are working together to plan strategies and share resources under the direction of the California Culture Change Coalition.
CAHF is excited and encouraged by CMS’ call to facilitate the formation of a partnership in California to reduce the unnecessary use of antipsychotic medications in nursing homes.
CAHF encourages all California facilities to participate in the focused effort to reduce off-label use of antipsychotic medications in long-term care.
2014 Antipsychotic Partnership Report